Clinical audit of 5 years provision of the Odstock dropped foot stimulator.
The Odstock dropped foot stimulator (ODFS) is a foot switch controlled single channel neuromuscular stimulator for correction of dropped foot. Following a randomized controlled trial, the ODFS was recommended for use in the United Kingdom's National Health Service and a clinical service established. The patient performance was assessed by measurement of walking speed over 10 m, physiological cost index (PCI), and by questionnaire. After 4.5 months stroke patients (n = 111) showed a mean increase in walking speed of 27% and reduction in PCI of 31% with stimulation and changes of 14% and 19%, respectively, unassisted. Multiple sclerosis patients (n = 21) gained similar orthotic benefit but no carry over. The principal reason cited for using the equipment was that it reduced the effort of walking. The principal reasons identified for discontinuing were an improvement in mobility, electrode positioning difficulties, and deteriorating mobility. A comprehensive clinical follow-up service is essential to achieve the maximum continuing benefit from FES based orthosis.
Taylor
P
P
Department of Medical Physics and Biomedical Engineering, Salisbury District Hospital, Wiltshire, UK.
Burridge
J
J
Dunkerley
A
A
Wood
D
D
Norton
J
J
Singleton
C
C
Swain
I
I
D002561:Cerebrovascular Disorders / Q000534:rehabilitation; D004599:Electric Stimulation Therapy / Q000295:instrumentation* / Q000379:methods; D004566:Electrodes; D005500:Follow-Up Studies; D005534:Foot Diseases / Q000534:rehabilitation*; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D008485:Medical Audit; D009103:Multiple Sclerosis / Q000534:rehabilitation; D009989:Orthotic Devices; D010352:Patient Dropouts; D017060:Patient Satisfaction; D016032:Randomized Controlled Trials as Topic; D020127:Recovery of Function; D013222:State Medicine; D011795:Surveys and Questionnaires; D006113:United Kingdom; D016138:Walking / Q000502:physiology